These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33075066)

  • 1. Clinical impact of angiographically insignificant suboptimal poststent findings detected by optical coherence tomography after drug-eluting stent implantation.
    Cho JY; Kook H; Yu CW
    PLoS One; 2020; 15(10):e0240860. PubMed ID: 33075066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Implications of Poststent Optical Coherence Tomographic Findings: Severe Malapposition and Cardiac Events.
    Kim BG; Kachel M; Kim JS; Guagliumi G; Kim C; Kim IS; Lee YJ; Lee OH; Byun YS; Kim BO; Milewski K; Lee SJ; Hong SJ; Ahn CM; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2022 Jan; 15(1):126-137. PubMed ID: 34023255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Frequency Domain Optical Coherence Tomography Compared with Intravascular Ultrasound as a Guidance for Percutaneous Coronary Intervention.
    Kim IC; Yoon HJ; Shin ES; Kim MS; Park J; Cho YK; Park HS; Kim H; Nam CW; Han SW; Kim YN; Kim KB; Hur SH
    J Interv Cardiol; 2016 Apr; 29(2):216-24. PubMed ID: 26927366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of late stent malapposition after drug-eluting stent implantation on long-term clinical outcomes.
    Im E; Lee SY; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Atherosclerosis; 2019 Sep; 288():118-123. PubMed ID: 31357039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
    Ali ZA; Maehara A; Généreux P; Shlofmitz RA; Fabbiocchi F; Nazif TM; Guagliumi G; Meraj PM; Alfonso F; Samady H; Akasaka T; Carlson EB; Leesar MA; Matsumura M; Ozan MO; Mintz GS; Ben-Yehuda O; Stone GW;
    Lancet; 2016 Nov; 388(10060):2618-2628. PubMed ID: 27806900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).
    Maehara A; Ben-Yehuda O; Ali Z; Wijns W; Bezerra HG; Shite J; Généreux P; Nichols M; Jenkins P; Witzenbichler B; Mintz GS; Stone GW
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1704-14. PubMed ID: 26585621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Clinical Outcomes of Late Stent Malapposition Detected by Optical Coherence Tomography After Drug-Eluting Stent Implantation.
    Im E; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    J Am Heart Assoc; 2019 Apr; 8(7):e011817. PubMed ID: 30905253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study.
    Prati F; Romagnoli E; Burzotta F; Limbruno U; Gatto L; La Manna A; Versaci F; Marco V; Di Vito L; Imola F; Paoletti G; Trani C; Tamburino C; Tavazzi L; Mintz GS
    JACC Cardiovasc Imaging; 2015 Nov; 8(11):1297-305. PubMed ID: 26563859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography assessment of incidence, morphological characteristics, and spontaneous healing course of edge dissections following percutaneous coronary intervention with stent implantation in patients with non-ST segment elevation myocardial infarction.
    Antonsen L; Thayssen P; Hansen HS; Junker A; Veien KT; Hansen KN; Hougaard M; Jensen LO
    Int J Cardiol; 2016 Nov; 223():466-474. PubMed ID: 27544607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation.
    Im E; Kim BK; Ko YG; Shin DH; Kim JS; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2014 Feb; 7(1):88-96. PubMed ID: 24425586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of late-acquired stent malapposition of drug eluting stents with second generation permanent and biodegradable polymer coatings-A prospective, randomized comparison using optical coherence tomography.
    Roth C; Gangl C; Dalos D; Delle-Karth G; Neunteufl T; Berger R
    J Interv Cardiol; 2018 Dec; 31(6):780-791. PubMed ID: 30479028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
    Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical characteristics and prognosis of lesions with in-stent eccentric tissue proliferation and strong signal attenuation detected by optical coherence tomography.
    Suzuki N; Kozuma K; Kyono H; Nakaya H; Nishide S; Mitsui M; Nara Y; Kawashima H; Nomura T; Yamamoto H; Sasajima Y; Kondo F; Isshiki T
    Cardiovasc Interv Ther; 2016 Jul; 31(3):210-7. PubMed ID: 26608163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Clinical Significance of Poststent Optical Coherence Tomography Findings: One-Year Follow-Up Study From a Multicenter Registry.
    Soeda T; Uemura S; Park SJ; Jang Y; Lee S; Cho JM; Kim SJ; Vergallo R; Minami Y; Ong DS; Gao L; Lee H; Zhang S; Yu B; Saito Y; Jang IK
    Circulation; 2015 Sep; 132(11):1020-9. PubMed ID: 26162917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of optical coherence tomography findings on clinical outcomes in ST-segment elevation myocardial infarction patients: a MATRIX (Minimizing Adverse Hemorrhagic Events by Trans-radial Access Site and angioX) OCT sub-study.
    Yacob O; Garcia-Garcia HM; Dan K; Soud M; Adamo M; Picchi A; Sardella G; Frigoli E; Limbruno U; Rigattieri S; Diletti R; Boccuzzi G; Zimarino M; Contarini M; Russo F; Calabro P; Ando G; Varbella F; Garducci S; Palmieri C; Briguori C; Kuku KO; Karagiannis A; Valgimigli M
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1143-1150. PubMed ID: 33225426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation.
    Jia H; Hu S; Liu H; Zhu Y; Zhe CY; Li L; Mustafina I; Hou J; Zhang S; Yu B
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):582-591. PubMed ID: 28318139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation.
    Radu MD; Räber L; Heo J; Gogas BD; Jørgensen E; Kelbæk H; Muramatsu T; Farooq V; Helqvist S; Garcia-Garcia HM; Windecker S; Saunamäki K; Serruys PW
    EuroIntervention; 2014 Jan; 9(9):1085-94. PubMed ID: 24064426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.